Anal Fissure Treatment Market Overview
A linear tear in the mucosal lining of the distal anal canal below the dentate line is known as an anal fissure. Severe pain during and after a bowel movement that lasts several minutes to several hours is a common symptom of an anal fissure. These fissures form mostly as a result of trauma to the anus's inner lining; most of the time, a hard, dry bowel movement is the cause, but diarrhea and loose stool have also been noted in some cases. Severe anal discomfort can cause the anal sphincter muscle to spasm, resulting in a reduction in blood flow to the injured site and, as a result, a delay in wound healing.
The following bowel movement causes greater anal spasm, pain, and decreased blood flow to the injured area, and so on. Treatments try to break this cycle by relaxing the anal sphincter muscle, allowing the fissure to heal. The majority of patients suffering from a chronic anal fissure are between the ages of 20 and 60. An anterior fissure is more likely to form in women (25%) than in men (8%), however, both males and females are affected equally by anal fissures.
Improper eating habits, particularly among people aged 13 to 25, as well as an ageing population and a demand for minimally invasive and quick-acting treatments, will drive the anal fissure market. The entire market is expected to rise, particularly in the age ranges of 15 to 30 years and 50 to 60 years, as these are the age groups with the most bowel movement difficulties.
| Report Metric | Details |
| Market size available for years | 2023–2030 |
| Base year considered | 2023 |
| Forecast period | 2024–2030 |
| Forecast unit | Value (USD Million) |
| Segments covered | Type, Route of Administration, End-User, and Region. |
| Regions covered | North America (the U.S. and Canada), Europe (UK, Germany, France, Italy, Spain, Russia, Rest of Europe), Asia-Pacific (China, India, Japan, Australia, South East Asia, Rest of Asia Pacific), Latin America and the Middle East and Africa (Brazil, Saudi Arabia, UAE, Rest of LAMEA) |
| Companies covered | Troikaa Pharmaceuticals Ltd., S.L.A. Pharma AG, M/S Dizney Display Company, Ipsen Inc., ProStrakan Group plc, RDD Pharma Ltd., RDD Pharma Ltd., Allergan, Inc. |
Covid-19 Impact on Anal Fissure Treatment Market
In addition, the current Anal Fissure Treatment Market study offers a detailed analysis of the current COVID-19 pandemic impact on the market growth and its influence on the future growth of the Anal Fissure Treatment Market. The recently published report demonstrates the elevation in the demand for the healthcare sector. The healthcare manufacturers have experienced long term as well as short term effect which includes supply shortages, panic buying, and stocking, regulation changes as short-term whereas approval delays and possible trend variations in consumption could be perceived as long-term impacts of COVID-19 on the health and pharmaceutical market.
The increasing need for a cure has pushed vaccine research and manufacturers to the limit. In addition to this, panic conditions have already spurred the demand for many healthcare products and services which are discussed in detail in this report. Moreover, the impact of COVID-19 on overall market revenue for the base year 2020 and its projection up to 2027 is provided in detail in this report.
Anal Fissure Treatment Market Segment Overview
Based on the Type, Surgery is one of the major segments in the global Anal Fissure Treatment market. Scarring or muscle spasms of the internal anal sphincter muscle might cause a fissure to fail to heal. To relieve pain and spasms and allow the fissure to heal, surgery usually involves cutting a tiny piece of the internal anal sphincter muscle. The ability to control bowel movements is rarely lost when a muscle is cut. Moreover, Medication is another main segment in the global market. To relieve inflammation, use hydrocortisone-containing suppositories, foams, or creams; apply additional lotions and ointments. A medicinal cream (to aid in the healing of the fissure), a topical muscle relaxant (to calm the anal muscles), an anesthetic ointment (to relieve pain if pain prevents from having a bowel movement), or nitroglycerin or calcium channel blocker ointments are some of the options (to relax the anal muscles and increase blood flow to the region, promoting healing).
Anal Fissure Treatment Market, By Type
- Surgery
- Medication
- Laxatives
- Calcium Channel Blocking Drugs
- Nitroglycerin
- Stool Softeners
- Steroids
- Botulinum Toxin
- Anesthetics
Anal Fissure Treatment Market, By Route of Administration
· Topical
· Oral
Anal Fissure Treatment Market, By End User
· Academic and Research Institutes
· Clinics
· Hospitals
Anal Fissure Treatment Regional Overview
Region-wise, North America commanded a major share of the market and is predictable to maintain its supremacy over the forecast period. The demand for chronic anal fissure therapy is increasing in major countries such as the United States and Canada, as a result of rising cases of many disorders such as constipation, Crohn's disease, and childbirth trauma. Moreover, Europe is the second-largest region for the market. The market will rise as fast-food consumption increases, as well other ailments such as chronic constipation and diarrhea, as well as the ageing population. Additionally, the presence of various biotech and pharmaceutical companies in the Asia-Pacific region is expected to drive significant growth. Finally, the Middle East and Africa will expand the slowest. It is owing to the rising number of health-related issues and bad dietary habits among the population. However, as more people become aware of the treatments for chronic anal fissures, this region will gradually increase.
Anal Fissure Treatment Market, By Geography
· North America (US & Canada)
· Europe (UK, Germany, France, Italy, Spain, Russia & Rest of Europe)
· Asia-Pacific (Japan, China, India, Australia, & South Korea, & Rest of Asia-Pacific)
· LAMEA (Brazil, Saudi Arabia, UAE & Rest of LAMEA)
Anal Fissure Treatment Market, Key Players
· Troikaa Pharmaceuticals Ltd.
· S.L.A. Pharma AG
· M/S Dizney Display Company
· Ipsen Inc.
· ProStrakan Group plc
· RDD Pharma Ltd.
· RDD Pharma Ltd.
· Allergan, Inc.
Frequently Asked Questions (FAQ) :
Q1. What are the driving factors for the global Anal Fissure Treatment market?
Improper eating habits, particularly among people aged 13 to 25, as well as an ageing population and a demand for minimally invasive and quick-acting treatments, will drive the anal fissure market.
Q2. Which Segments are covered in the global Anal Fissure Treatment market report?
Type, Route of Administration, End-User, and Region. these segments are covered in the global Anal Fissure Treatment market report
Q3. Which segment is projected to hold the largest share in the global Anal Fissure Treatment market. ?
Surgery segments are projected to hold the largest share in the global Anal Fissure Treatment market.
Q4. Which region holds the largest share in the global Anal Fissure Treatment market?
North America held the largest share in the global Anal Fissure Treatment market.
Q5. Which are the prominent players in the global Anal Fissure Treatment market?
Troikaa Pharmaceuticals Ltd., S.L.A. Pharma AG, M/S Dizney Display Company, Ipsen Inc., ProStrakan Group plc, RDD Pharma Ltd., RDD Pharma Ltd., Allergan, Inc. are some key players in the global Anal Fissure Treatment market.
1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
4. Key Insights
- 4.1. Key Emerging Trends – For Major Countries
- 4.2. Latest Technological Advancement
- 4.3. Regulatory Landscape
- 4.4. Industry SWOT Analysis
- 4.5. Porters Five Forces Analysis
5. Global Anal Fissure Treatment Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 5.1. Key Findings / Summary
- 5.2. Market Analysis, Insights and Forecast – By Type
- 5.2.1. Surgery
- 5.2.2. Medication
- 5.2.2.1. Laxatives
- 5.2.2.2. Calcium Channel Blocking Drugs
- 5.2.2.3. Nitroglycerin
- 5.2.2.4. Stool Softeners
- 5.2.2.5. Steroids
- 5.2.2.6. Botulinum Toxin
- 5.2.2.7. Anesthetics
- 5.3.1. Topical
- 5.3.2. Oral
- 5.4.1. Academic and Research Institutes
- 5.4.2. Clinics
- 5.4.3. Hospitals
- 5.5.1. North America
- 5.5.2. Europe
- 5.5.3. Asia Pacific
- 5.5.4. Latin America, Middle East and Africa
6. North America Anal Fissure Treatment Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 6.1. Key Findings / Summary
- 6.2. Market Analysis, Insights and Forecast – By Type
- 6.2.1. Surgery
- 6.2.2. Medication
- 6.2.2.1. Laxatives
- 6.2.2.2. Calcium Channel Blocking Drugs
- 6.2.2.3. Nitroglycerin
- 6.2.2.4. Stool Softeners
- 6.2.2.5. Steroids
- 6.2.2.6. Botulinum Toxin
- 6.2.2.7. Anesthetics
- 6.3.1. Topical
- 6.3.2. Oral
- 6.4.1. Academic and Research Institutes
- 6.4.2. Clinics
- 6.4.3. Hospitals
- 6.5.1. U.S.
- 6.5.2. Canada
7. Europe Anal Fissure Treatment Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 7.1. Key Findings / Summary
- 7.2. Market Analysis, Insights and Forecast – By Type
- 7.2.1. Surgery
- 7.2.2. Medication
- 7.2.2.1. Laxatives
- 7.2.2.2. Calcium Channel Blocking Drugs
- 7.2.2.3. Nitroglycerin
- 7.2.2.4. Stool Softeners
- 7.2.2.5. Steroids
- 7.2.2.6. Botulinum Toxin
- 7.2.2.7. Anesthetics
- 7.3.1. Topical
- 7.3.2. Oral
- 7.4.1. Academic and Research Institutes
- 7.4.2. Clinics
- 7.4.3. Hospitals
- 7.5.1. UK
- 7.5.2. Germany
- 7.5.3. France
- 7.5.4. Italy
- 7.5.5. Spain
- 7.5.6. Russia
- 7.5.7. Rest of Europe
8. Asia Pacific Anal Fissure Treatment Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 8.1. Key Findings / Summary
- 8.2. Market Analysis, Insights and Forecast – By Type
- 8.2.1. Surgery
- 8.2.2. Medication
- 8.2.2.1. Laxatives
- 8.2.2.2. Calcium Channel Blocking Drugs
- 8.2.2.3. Nitroglycerin
- 8.2.2.4. Stool Softeners
- 8.2.2.5. Steroids
- 8.2.2.6. Botulinum Toxin
- 8.2.2.7. Anesthetics
- 8.3.1. Topical
- 8.3.2. Oral
- 8.4.1. Academic and Research Institutes
- 8.4.2. Clinics
- 8.4.3. Hospitals
- 8.5.1. China
- 8.5.2. India
- 8.5.3. Japan
- 8.5.4. Australia
- 8.5.5. South East Asia
- 8.5.6. Rest of Asia Pacific
9. Latin America, Middle East and Africa Anal Fissure Treatment Market Analysis (USD Billion), Insights and Forecast, 2020-2027
- 9.1. Key Findings / Summary
- 9.2. Market Analysis, Insights and Forecast – By Type
- 9.2.1. Surgery
- 9.2.2. Medication
- 9.2.2.1. Laxatives
- 9.2.2.2. Calcium Channel Blocking Drugs
- 9.2.2.3. Nitroglycerin
- 9.2.2.4. Stool Softeners
- 9.2.2.5. Steroids
- 9.2.2.6. Botulinum Toxin
- 9.2.2.7. Anesthetics
- 9.3.1. Topical
- 9.3.2. Oral
- 9.4.1. Academic and Research Institutes
- 9.4.2. Clinics
- 9.4.3. Hospitals
- 9.5.1. Brazil
- 9.5.2. Saudi Arabia
- 9.5.3. UAE
- 9.5.4. Rest of LAMEA
10. Competitive Analysis
- 10.1. Company Market Share Analysis, 2018
- 10.2. Key Industry Developments
- 10.3. Company Profile
- 10.4. Troikaa Pharmaceuticals Ltd.
- 10.4.1. Business Overview
- 10.4.2. Segment 1 & Service Offering
- 10.4.3. Overall Revenue
- 10.4.4. Geographic Presence
- 10.4.5. Recent Development
- 10.5. S.L.A. Pharma AG
- 10.6. M/S Dizney Display Company
- 10.7. Ipsen Inc.
- 10.8. ProStrakan Group plc
- 10.9. RDD Pharma Ltd.
- 10.10. RDD Pharma Ltd.
Data Library Research are conducted by industry experts who offer insight on industry structure, market segmentations technology assessment and competitive landscape (CL), and penetration, as well as on emerging trends. Their analysis is based on primary interviews (~ 80%) and secondary research (~ 20%) as well as years of professional expertise in their respective industries. Adding to this, by analysing historical trends and current market positions, our analysts predict where the market will be headed for the next five years. Furthermore, the varying trends of segment & categories geographically presented are also studied and the estimated based on the primary & secondary research.
In this particular report from the supply side Data Library Research has conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and SOFT) of the companies that active & prominent as well as the midsized organization
FIGURE 1: DLR RESEARH PROCESS
Extensive primary research was conducted to gain a deeper insight of the market and industry performance. The analysis is based on both primary and secondary research as well as years of professional expertise in the respective industries.
In addition to analysing current and historical trends, our analysts predict where the market is headed over the next five years.
It varies by segment for these categories geographically presented in the list of market tables. Speaking about this particular report we have conducted primary surveys (interviews) with the key level executives (VP, CEO’s, Marketing Director, Business Development Manager and many more) of the major players active in the market.
Secondary ResearchSecondary research was mainly used to collect and identify information useful for the extensive, technical, market-oriented, and Friend’s study of the Global Extra Neutral Alcohol. It was also used to obtain key information about major players, market classification and segmentation according to the industry trends, geographical markets, and developments related to the market and technology perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, sec filings, journals, white papers, SOFT presentations, and company web sites.
Market Size EstimationBoth, top-down and bottom-up approaches were used to estimate and validate the size of the Global market and to estimate the size of various other dependent submarkets in the overall Extra Neutral Alcohol. The key players in the market were identified through secondary research and their market contributions in the respective geographies were determined through primary and secondary research.
Forecast Model
